Janux Therapeutics Statistics
NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.92+1.13 (+6.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 18.50 +3.24%
Janux Therapeutics by the numbers
Janux Therapeutics has a market capitalization of $1.10 billion based on 61.14M shares outstanding. With trailing EPS of $-1.64, Janux Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.6% above its 50-day average and 19.3% above its 200-day average.
Average daily trading volume is 839.02K shares, or about $15.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
JANX valuation vs. peer median
| Metric | JANX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.10B | $1.03B | +6% |
| Avg. volume | 839.02K | 595.60K | +41% |
Peer median across 8 companies: LTGO, OPK, PCRX, SVRA, AKTS, AMPH, BCAX, TRAX.
Valuation
- Market cap
- $1.10B
- EPS (TTM)
- $-1.64
- Shares outstanding
- 61.14M
Price and trading
- Previous close
- 16.79
- Open
- 16.52
- Day range
- 16.42 – 18.37
- 52-week range
- 12.12 – 35.34
- 52-week change
- -21.02%
- Beta
- —
- Volume
- 1.21M
- Average volume
- 839.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.10B
- Forward Pe
- -6.83
- Eps
- -1.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 35.34
- Week52 Low
- 12.12
- Avg Volume
- 839.02K
- Shares Outstanding
- 61.14M
- Ma50
- 17.13
- Ma200
- 15.02
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -49.29%
- Pct From52w Low
- 47.85%